Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commercialising its nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Glenmark Specialty, a Switzerland-based unit…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
Price War In Anti Diabetic Medicine Segment
A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…
